文献速递治疗药物监测与药物基因组学药物相互作用

药物研发中溶质载体与ATP结合盒转运蛋白的新兴研究:国际转运蛋白联盟展望

New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium.
PubMed 文献 · Clin Pharmacol Ther · 2022-05-20

该文综述了膜转运蛋白在基础、转化和临床研究中的最新进展。基础层面描述了SLC和ABC超家族转运蛋白的冷冻电镜结构及溶酶体、线粒体转运蛋白研究;转化层面总结了蛋白质组学、别构调节剂和靶向蛋白降解剂等方法;临床层面介绍了药物基因组学和精准医学工具。

要点

  • 冷冻电镜技术推动了SLC和ABC转运蛋白结构解析。
  • 蛋白质组学实现转运蛋白水平的定量理解。
  • 别构调节剂和靶向蛋白降解剂可调控转运蛋白功能。

核心结论

  • 膜转运蛋白研究在基础、转化和临床层面均取得显著进展,为药物研发和精准医学提供新工具。

研究设计与样本

  • 综述文章,总结了膜转运蛋白在药物发现与开发中的最新研究进展,涵盖基础、转化和临床研究。

主要发现

  • 冷冻电镜方法促进了SLC和ABC超家族转运蛋白晶体结构的解析。
  • 蛋白质组学研究实现了对各种细胞类型和组织中转运蛋白水平的定量理解。
  • 别构调节剂和靶向蛋白降解剂是调控转运蛋白功能的新方法。
  • 肠道微生物组可调节转运蛋白功能。
  • 3D细胞培养可能实现转运蛋白功能的体内预测。

临床怎么用

  • 利用蛋白质组学定量数据理解转运蛋白水平。
  • 应用别构调节剂和靶向蛋白降解剂调控转运蛋白功能。
  • 考虑肠道微生物组对转运蛋白功能的影响。
  • 采用3D细胞培养预测转运蛋白功能。
  • 应用组织来源小细胞外囊泡和真实世界生物标志物实现精准医学。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Enabled by a plethora of new technologies, research in membrane transporters has exploded in the past decade. The goal of this state-of-the-art article is to describe recent advances in research on membrane transporters that are particularly relevant to drug discovery and development. This review covers advances in basic, translational, and clinical research that has led to an increased understanding of membrane transporters at all levels. At the basic level, we describe the available crystal structures of membrane transporters in both the solute carrier (SLC) and ATP binding cassette superfamilies, which has been enabled by the development of cryogenic electron microscopy methods. Next, we describe new research on lysosomal and mitochondrial transporters as well as recently deorphaned transporters in the SLC superfamily. The translational section includes a summary of proteomic research, which has led to a quantitative understanding of transporter levels in various cell types and tissues and new methods to modulate transporter function, such as allosteric modulators and targeted protein degraders of transporters. The section ends with a review of the effect of the gut microbiome on modulation of transporter function followed by a presentation of 3D cell cultures, which may enable in vivo predictions of transporter function. In the clinical section, we describe new genomic and pharmacogenomic research, highlighting important polymorphisms in transporters that are clinically relevant to many drugs. Finally, we describe new clinical tools, which are becoming increasingly available to enable precision medicine, with the application of tissue-derived small extracellular vesicles and real-world biomarkers.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Giacomini KM, Yee SW, Koleske ML, et al. New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium. Clin Pharmacol Ther. 2022. PMID: 35488474. doi:10.1002/cpt.2627

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。